144 related articles for article (PubMed ID: 32877432)
1. Cost-effectiveness of a new autoantibody test added to Computed Tomography (CT) compared to CT surveillance alone in the diagnosis of lung cancer amongst patients with indeterminate pulmonary nodules.
Sutton AJ; Sagoo GS; Jackson L; Fisher M; Hamilton-Fairley G; Murray A; Hill A
PLoS One; 2020; 15(9):e0237492. PubMed ID: 32877432
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of an autoantibody test (EarlyCDT-Lung) as an aid to early diagnosis of lung cancer in patients with incidentally detected pulmonary nodules.
Edelsberg J; Weycker D; Atwood M; Hamilton-Fairley G; Jett JR
PLoS One; 2018; 13(5):e0197826. PubMed ID: 29787590
[TBL] [Abstract][Full Text] [Related]
3. Detection in blood of autoantibodies to tumour antigens as a case-finding method in lung cancer using the EarlyCDT®-Lung Test (ECLS): study protocol for a randomized controlled trial.
Sullivan FM; Farmer E; Mair FS; Treweek S; Kendrick D; Jackson C; Robertson C; Briggs A; McCowan C; Bedford L; Young B; Vedhara K; Gallant S; Littleford R; Robertson J; Sewell H; Dorward A; Sarvesvaran J; Schembri S
BMC Cancer; 2017 Mar; 17(1):187. PubMed ID: 28284200
[TBL] [Abstract][Full Text] [Related]
4. Autoantibody Signature Enhances the Positive Predictive Power of Computed Tomography and Nodule-Based Risk Models for Detection of Lung Cancer.
Massion PP; Healey GF; Peek LJ; Fredericks L; Sewell HF; Murray A; Robertson JF
J Thorac Oncol; 2017 Mar; 12(3):578-584. PubMed ID: 27615397
[TBL] [Abstract][Full Text] [Related]
5. Cost-Effectiveness of Treatment Thresholds for Subsolid Pulmonary Nodules in CT Lung Cancer Screening.
Hammer MM; Eckel AL; Palazzo LL; Kong CY
Radiology; 2021 Sep; 300(3):586-593. PubMed ID: 34128723
[TBL] [Abstract][Full Text] [Related]
6. Conventional Computed Tomographic Calcium Scoring vs full chest CTCS for lung cancer screening: a cost-effectiveness analysis.
Jiang B; Linden PA; Gupta A; Jarrett C; Worrell SG; Ho VP; Perry Y; Towe CW;
BMC Pulm Med; 2020 Jul; 20(1):187. PubMed ID: 32631384
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness analysis of screening for lung cancer with low dose spiral CT (computed tomography) in the Australian setting.
Manser R; Dalton A; Carter R; Byrnes G; Elwood M; Campbell DA
Lung Cancer; 2005 May; 48(2):171-85. PubMed ID: 15829317
[TBL] [Abstract][Full Text] [Related]
8. 18FDG-PET-CT in the follow-up of non-small cell lung cancer patients after radical radiotherapy with or without chemotherapy: an economic evaluation.
van Loon J; Grutters JP; Wanders R; Boersma L; Dingemans AM; Bootsma G; Geraedts W; Pitz C; Simons J; Brans B; Snoep G; Hochstenbag M; Lambin P; De Ruysscher D
Eur J Cancer; 2010 Jan; 46(1):110-9. PubMed ID: 19944595
[TBL] [Abstract][Full Text] [Related]
9. Colorectal cancer with indeterminate pulmonary nodules.
Jiang ZK; Xie YK; Huang JQ; Chen JS
Neoplasma; 2020 May; 67(3):439-449. PubMed ID: 32122141
[TBL] [Abstract][Full Text] [Related]
10. Lung cancer screening with helical computed tomography in older adult smokers: a decision and cost-effectiveness analysis.
Mahadevia PJ; Fleisher LA; Frick KD; Eng J; Goodman SN; Powe NR
JAMA; 2003 Jan; 289(3):313-22. PubMed ID: 12525232
[TBL] [Abstract][Full Text] [Related]
11. Exploratory cost-effectiveness model of electromagnetic navigation bronchoscopy (ENB) compared with CT-guided biopsy (TTNA) for diagnosis of malignant indeterminate peripheral pulmonary nodules.
Rickets W; Lau KKW; Pollit V; Mealing S; Leonard C; Mallender P; Chaudhuri N; Shah PL; Naidu UB
BMJ Open Respir Res; 2020 Aug; 7(1):. PubMed ID: 32796019
[TBL] [Abstract][Full Text] [Related]
12. Computed tomography screening for lung cancer in Hodgkin's lymphoma survivors: decision analysis and cost-effectiveness analysis.
Das P; Ng AK; Earle CC; Mauch PM; Kuntz KM
Ann Oncol; 2006 May; 17(5):785-93. PubMed ID: 16500905
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of a low-dose computed tomography screening programme for lung cancer in New Zealand.
Jaine R; Kvizhinadze G; Nair N; Blakely T
Lung Cancer; 2018 Oct; 124():233-240. PubMed ID: 30268467
[TBL] [Abstract][Full Text] [Related]
14. Indeterminate Pulmonary Nodules in Colorectal Cancer: Follow-up Guidelines Based on a Risk Predictive Model.
Kim CH; Huh JW; Kim HR; Kim YJ
Ann Surg; 2015 Jun; 261(6):1145-52. PubMed ID: 25119121
[TBL] [Abstract][Full Text] [Related]
15. Assessment of indeterminate pulmonary nodules detected in lung cancer screening: Diagnostic accuracy of FDG PET/CT.
Garcia-Velloso MJ; Bastarrika G; de-Torres JP; Lozano MD; Sanchez-Salcedo P; Sancho L; Nuñez-Cordoba JM; Campo A; Alcaide AB; Torre W; Richter JA; Zulueta JJ
Lung Cancer; 2016 Jul; 97():81-6. PubMed ID: 27237032
[TBL] [Abstract][Full Text] [Related]
16. Low-dose computed tomography for lung cancer screening in high-risk populations: a systematic review and economic evaluation.
Snowsill T; Yang H; Griffin E; Long L; Varley-Campbell J; Coelho H; Robinson S; Hyde C
Health Technol Assess; 2018 Nov; 22(69):1-276. PubMed ID: 30518460
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness analysis of LungLB for the clinical management of patients with indeterminate pulmonary nodules.
Schneider JE; Davies S; Do Valle M; Chami N; Pagano PC; Anderson D; Donovan MJ
J Med Econ; 2023; 26(1):342-347. PubMed ID: 36802981
[TBL] [Abstract][Full Text] [Related]
18. Analytical decision model for the cost-effective management of solitary pulmonary nodules.
Gambhir SS; Shepherd JE; Shah BD; Hart E; Hoh CK; Valk PE; Emi T; Phelps ME
J Clin Oncol; 1998 Jun; 16(6):2113-25. PubMed ID: 9626211
[TBL] [Abstract][Full Text] [Related]
19. Incidental Pulmonary Nodules Are Common on CT Coronary Angiogram and Have a Significant Cost Impact.
Robertson J; Nicholls S; Bardin P; Ptasznik R; Steinfort D; Miller A
Heart Lung Circ; 2019 Feb; 28(2):295-301. PubMed ID: 29337086
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of FDG-PET/CT for cytologically indeterminate thyroid nodules: a decision analytic approach.
Vriens D; Adang EM; Netea-Maier RT; Smit JW; de Wilt JH; Oyen WJ; de Geus-Oei LF
J Clin Endocrinol Metab; 2014 Sep; 99(9):3263-74. PubMed ID: 24873995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]